Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226,220,429
-
Total 13F shares
-
73,319,077
-
Share change
-
+1,764,269
-
Total reported value
-
$1,426,826,188
-
Put/Call ratio
-
110%
-
Price per share
-
$19.44
-
Number of holders
-
112
-
Value change
-
+$28,190,602
-
Number of buys
-
52
-
Number of sells
-
52
Institutional Holders of Allogene Therapeutics, Inc. - Common Stock (ALLO) as of Q1 2020
As of 31 Mar 2020 Allogene Therapeutics, Inc. - Common Stock (ALLO) had 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 73,319,077 shares of stock of the company.
Largest 10 holders included TPG Group Holdings (SBS) Advisors, Inc., Capital Research Global Investors, BlackRock Inc., Capital International Investors, VANGUARD GROUP INC, FMR LLC, Capital World Investors, REGENTS OF THE UNIVERSITY OF CALIFORNIA, VV Manager LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This table shows 113 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.